The effect of noninvasive brain stimulation on anhedonia in patients with schizophrenia and depression: A systematic review and meta-analysis

Abstract

Anhedonia is a transdiagnostic symptom found in patients with schizophrenia and depression. Current pharmacological interventions for anhedonia are unsatisfactory in a considerable proportion of patients. There has been growing interest in applying noninvasive brain stimulation (NIBS) to patients with anhedonia. However, evidence for the efficacy of NIBS for anhedonia remain inconsistent. This study systematically identified all studies that measured anhedonia and applied NIBS in patients with schizophrenia or depression. We conducted a search using the various databases in English (PubMed, EBSCOHost (PsycInfo/PsycArticles), Web of Science) and Chinese (China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform) languages, and reviewed original research articles on NIBS published from January 1989 to July 2023. Our search had identified 15 articles for quantitative synthesis, with three concerning schizophrenia samples, 11 concerning samples with depression, and one concerning both clinical samples. We conducted a meta-analysis based on the 15 included studies, and the results suggested that NIBS could improve anhedonia symptoms in schizophrenia patients and patients with depression, with a medium-to-large effect size. Our findings are preliminary, given the limited number of included studies. Future NIBS research should measure anhedonia as a primary outcome and should recruit transdiagnostic samples.

Keywords

anhedonia / depression / meta-analysis / noninvasive brain stimulation / schizophrenia

References

[1] Ahn, H. M., Kim, S. E., & Kim, S. H. (2013). The effects of high-frequency rTMS over the left dorsolateral prefrontal cortex on reward responsiveness. Brain Stimulation, 6(3), 310–314.

[2] Alam, M., Truong, D. Q., Khadka, N., & Bikson, M. (2016). Spatial and polarity precision of concentric high-definition transcranial direct current stimulation (HD-tDCS). Physics in Medicine and Biology, 61(12), 4506–4521.

[3] Bhattacharya, A., Mrudula, K., Sreepada, S. S., Sathyaprabha, T. N., Pal, P. K., Chen, R., & Udupa, K. (2022). An overview of noninvasive brain stimulation: Basic principles and clinical applications. Canadian Journal of Neurological Sciences, 49(4), 479–492.

[4] Bodén, R., Bengtsson, J., Thörnblom, E., Struckmann, W., & Persson, J. (2021). Dorsomedial prefrontal theta burst stimulation to treat anhedonia, avolition, and blunted affect in schizophrenia or depression—a randomized controlled trial. Journal of Affective Disorders, 290, 308–315.

[5] Camacho-Conde, J. A., Del Rosario Gonzalez-Bermudez, M., Carretero-Rey, M., & Khan, Z. U. (2022). Therapeutic potential of brain stimulation techniques in the treatment of mental, psychiatric, and cognitive disorders. CNS Neuroscience & Therapeutics, 29, 8–23.

[6] Dhami, P., Knyahnytska, Y., Atluri, S., Lee, J., Courtney, D. B., Croarkin, P. E., Blumberger, D. M., Daskalakis, Z. J., & Farzan, F. (2019). Feasibility and clinical effects of theta burst stimulation in youth with major depressive disorders: An open-label trial. Journal of Affective Disorders, 258, 66–73.

[7] Diederichs, C., DeMayo, M. M., Cole, J., Yatham, L. N., Harris, A. D., & McGirr, A. (2021). Intermittent theta-burst stimulation transcranial magnetic stimulation increases GABA in the medial prefrontal cortex: A preliminary sham-controlled magnetic resonance spectroscopy study in acute bipolar depression. Frontiers in Psychiatry, 12, 665402.

[8] Downar, J., Geraci, J., Salomons, T. V., Dunlop, K., Wheeler, S., McAndrews, M. P., Bakker, N., Blumberger, D. M., Daskalakis, Z. J., Kennedy, S. H., Flint, A. J., & Giacobbe, P. (2014). Anhedonia and reward-circuit connectivity distinguish nonresponders from responders to dorsomedial prefrontal repetitive transcranial magnetic stimulation in major depression. Biological Psychiatry, 76(3), 176–185.

[9] Duprat, R., Wu, G. R., De Raedt, R., & Baeken, C. (2018). Accelerated iTBS treatment in depressed patients differentially modulates reward system activity based on anhedonia. World Journal of Biological Psychiatry, 19(7), 497–508.

[10] Elemery, M., Kiss, S., Dome, P., Pogany, L., Faludi, G., & Lazary, J. (2022). Change of circulating vascular endothelial growth factor level and reduction of anhedonia are associated in patients with major depressive disorder treated with repetitive transcranial magnetic stimulation. Frontiers in Psychiatry, 13, 806731.

[11] Fiene, M., Schwab, B. C., Misselhorn, J., Herrmann, C. S., Schneider, T. R., & Engel, A. K. (2020). Phase-specific manipulation of rhythmic brain activity by transcranial alternating current stimulation. Brain Stimulation, 13(5), 1254–1262.

[12] Fukuda, A. M., Kang, J. W. D., Gobin, A. P., Tirrell, E., Kokdere, F., & Carpenter, L. L. (2021). Effects of transcranial magnetic stimulation on anhedonia in treatment resistant major depressive disorder. Brain and Behavior, 11(9), e2329.

[13] Fusar-Poli, P., Papanastasiou, E., Stahl, D., Rocchetti, M., Carpenter, W., Shergill, S., & McGuire, P. (2015). Treatments of negative symptoms in schizophrenia: Meta-analysis of 168 randomized placebo-controlled trials. Schizophrenia Bulletin, 41(4), 892–899.

[14] Gan, H., Zhu, J., Zhuo, K., Zhang, J., Tang, Y., Qian, Z., Xiang, Q., Li, X., Zhu, Y., Wang, J., Wang, J., & Liu, D. (2021). High frequency repetitive transcranial magnetic stimulation of dorsomedial prefrontal cortex for negative symptoms in patients with schizophrenia: A double-blind, randomized controlled trial. Psychiatry Research, 299, 113876.

[15] Goodwin, G. M., Price, J., De Bodinat, C., & Laredo, J. (2017). Emotional blunting with antidepressant treatments: A survey among depressed patients. Journal of Affective Disorders, 221, 31–35.

[16] Gupta, T., Kelley, N. J., Pelletier-Baldelli, A., & Mittal, V. A. (2018). Transcranial direct current stimulation, symptomatology, and cognition in psychosis: A qualitative review. Frontiers in Behavioral Neuroscience, 12, 94.

[17] Higgins, J. P., & Altman, D. G. (2008). Assessing risk of bias in included studies. In J. P. T. Higgins, J. Thomas, J. Chandler, M. Cumpston, T. Li, M. J. Page, & V. A. Welch (Eds.), Cochrane handbook for systematic reviews of interventions (pp. 187–241). The Cochrane Collaboration and John Wiley & Sons.

[18] Homan, S., Muscat, W., Joanlanne, A., Marousis, N., Cecere, G., Hofmann, L., Ji, E., Neumeier, M., Vetter, S., Seifritz, E., Dierks, T., & Homan, P. (2021). Treatment effect variability in brain stimulation across psychiatric disorders: A meta-analysis of variance. Neuroscience & Biobehavioral Reviews, 124, 54–62.

[19] Hultcrantz, M., Rind, D., Akl, E. A., Treweek, S., Mustafa, R. A., Iorio, A., Alper, B. S., Meerpohl, J. J., Murad, M. H., Ansari, M. T., Katikireddi, S. V., Östlund, P., Tranæus, S., Christensen, R., Gartlehner, G., Brozek, J., Izcovich, A., Schünemann, H., & Guyatt, G. (2017). The GRADE working group clarifies the construct of certainty of evidence. Journal of Clinical Epidemiology, 87, 4–13.

[20] Jannati, A., Oberman, L. M., Rotenberg, A., & Pascual-Leone, A. (2023). Assessing the mechanisms of brain plasticity by transcranial magnetic stimulation. Neuropsychopharmacology, 48(1), 191–208.

[21] Jog, M. S., Kim, E., Anderson, C., Kubicki, A., Kayathi, R., Jann, K., Yan, L., Leaver, A., Hellemann, G., Iacoboni, M., Woods, R. P., Wang, D. J. J., & Narr, K. L. (2021). In-vivo imaging of targeting and modulation of depression-relevant circuitry by transcranial direct current stimulation: A randomized clinical trial. Translational Psychiatry, 11(1), 138.

[22] Kaboodvand, N., Iravani, B., van den Heuvel, M. P., Persson, J., & Boden, R. (2023). Macroscopic resting state model predicts theta burst stimulation response: A randomized trial. PLoS Computational Biology, 19(3), e1010958.

[23] Krepel, N., Rush, A. J., Iseger, T. A., Sack, A. T., & Arns, M. (2020). Can psychological features predict antidepressant response to rTMS? A discovery-replication approach. Psychological Medicine, 50(2), 264–272.

[24] Kumar, N., Vishnubhatla, S., Wadhawan, A. N., Minhas, S., & Gupta, P. (2020). A randomized, double blind, sham-controlled trial of repetitive transcranial magnetic stimulation (rTMS) in the treatment of negative symptoms in schizophrenia. Brain Stimulation, 13(3), 840–849.

[25] Kuo, H. I., Bikson, M., Datta, A., Minhas, P., Paulus, W., Kuo, M. F., & Nitsche, M. A. (2013). Comparing cortical plasticity induced by conventional and high-definition 4 × 1 ring tDCS: A neurophysiological study. Brain Stimulation, 6(4), 644–648.

[26] Lambert, C., Da Silva, S., Ceniti, A. K., Rizvi, S. J., Foussias, G., & Kennedy, S. H. (2018). Anhedonia in depression and schizophrenia: A transdiagnostic challenge. CNS Neuroscience & Therapeutics, 24(7), 615–623.

[27] Lazary, J., Elemery, M., Dome, P., Kiss, S., Gonda, X., Tombor, L., Pogany, L., Becskereki, G., Toth, B., & Faludi, G. (2021). Peripheral endocannabinoid serum level in association with repetitive transcranial magnetic stimulation (rTMS) treatment in patients with major depressive disorder. Scientific Reports, 11(1), 8867.

[28] Li, Q., Fu, Y., Liu, C., & Meng, Z. (2022). Transcranial direct current stimulation of the dorsolateral prefrontal cortex for treatment of neuropsychiatric disorders. Frontiers in Behavioral Neuroscience, 16, 893955.

[29] Li, Y., Mou, X., Jiang, W., Yang, Z., Shen, X., Jin, Z., Dai, Z., Liu, Y., Mao, S., Zhang, J., & Yuan, Y. (2015). A comparative study of anhedonia components between major depression and schizophrenia in Chinese populations. Annals of General Psychiatry, 14, 24.

[30] Liang, S., Wu, Y., Hanxiaoran, L., Greenshaw, A. J., & Li, T. (2022). Anhedonia in depression and schizophrenia: Brain reward and aversion circuits. Neuropsychiatric Disease and Treatment, 18, 1385–1396.

[31] Light, S. N., Bieliauskas, L. A., & Taylor, S. F. (2019). Measuring change in anhedonia using the "happy faces" task pre- to post-repetitive transcranial magnetic stimulation (rTMS) treatment to left dorsolateral prefrontal cortex in major depressive disorder (MDD): Relation to empathic happiness. Translational Psychiatry, 9(1), 217.

[32] Marder, K. G., Barbour, T., Ferber, S., Idowu, O., & Itzkoff, A. (2022). Psychiatric applications of repetitive transcranial magnetic stimulation. Focus (American Psychiatric Publishing), 20(1), 8–18.

[33] Muszkat, D., Polanczyk, G. V., Dias, T. G., & Brunoni, A. R. (2016). Transcranial direct current stimulation in child and adolescent psychiatry. Journal of Child and Adolescent Psychopharmacology, 26(7), 590–597.

[34] Nitsche, M. A., Cohen, L. G., Wassermann, E. M., Priori, A., Lang, N., Antal, A., Paulus, W., Hummel, F., Boggio, P. S., Fregni, F., & Pascual-Leone, A. (2008). Transcranial direct current stimulation: State of the art 2008. Brain Stimulation, 1(3), 206–223.

[35] Prikryl, R., Ustohal, L., Prikrylova Kucerova, H., Kasparek, T., Venclikova, S., Vrzalova, M., & Ceskova, E. (2013). A detailed analysis of the effect of repetitive transcranial magnetic stimulation on negative symptoms of schizophrenia: A double-blind trial. Schizophrenia Research, 149(1–3), 167–173.

[36] Rezaei, M., Shariat Bagheri, M. M., & Ahmadi, M. (2021). Clinical and demographic predictors of response to anodal tDCS treatment in major depression disorder (MDD). Journal of Psychiatric Research, 138, 68–74.

[37] Rezaei, M., Shariat Bagheri, M. M., Khazaei, S., & Garavand, H. (2023). tDCS efficacy and utility of anhedonia and rumination as clinical predictors of response to tDCS in major depressive disorder (MDD). Journal of Affective Disorders, 339, 756–762.

[38] Rossi, S., Hallett, M., Rossini, P. M., & Pascual-Leone, A. (2009). Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clinical Neurophysiology, 120(12), 2008–2039.

[39] Russo, G. B., Tirrell, E., Busch, A., & Carpenter, L. L. (2018). Behavioral activation therapy during transcranial magnetic stimulation for major depressive disorder. Journal of Affective Disorders, 236, 101–104.

[40] Shi, C., Yu, X., Cheung, E. F., Shum, D. H., & Chan, R. C. (2014). Revisiting the therapeutic effect of rTMS on negative symptoms in schizophrenia: A meta-analysis. Psychiatry Research, 215(3), 505–513.

[41] Siddiqi, S. H., Haddad, N., & Fox, M. D. (2022). Circuit-targeted neuromodulation for anhedonia. Current Topics in Behavioral Neurosciences, 58, 515–535.

[42] Spano, M. C., Lorusso, M., Pettorruso, M., Zoratto, F., Di Giuda, D., Martinotti, G., & di Giannantonio, M. (2019). Anhedonia across borders: Transdiagnostic relevance of reward dysfunction for noninvasive brain stimulation endophenotypes. CNS Neuroscience & Therapeutics, 25(11), 1229–1236.

[43] Strafella, A. P., Paus, T., Barrett, J., & Dagher, A. (2001). Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. Journal of Neuroscience, 21(15), Rc157.

[44] Su, Y. A., & Si, T. (2022). Progress and challenges in research of the mechanisms of anhedonia in major depressive disorder. General Psychiatry, 35(1), e100724.

[45] Trifu, S., Sevcenco, A., Stănescu, M., Drăgoi, A. M., & Cristea, M. B. (2021). Efficacy of electroconvulsive therapy as a potential first-choice treatment in treatment-resistant depression. Experimental and Therapeutic Medicine, 22, 1281.

[46] To, W. T., Hart, J., De Ridder, D., & Vanneste, S. (2016). Considering the influence of stimulation parameters on the effect of conventional and high-definition transcranial direct current stimulation. Expert Review of Medical Devices, 13(4), 391–404.

[47] Treadway, M. T., & Zald, D. H. (2011). Reconsidering anhedonia in depression: Lessons from translational neuroscience. Neuroscience & Biobehavioral Reviews, 35(3), 537–555.

[48] Tseng, P.-T., Zeng, B.-S., Hung, C.-M., Liang, C.-S., Stubbs, B., Carvalho, A. F., Brunoni, A. R., Su, K.-P., Tu, Y.-K., Wu, Y.-C., Chen, T.-Y., Li, D.-J., Lin, P.-Y., Hsu, C.-W., Chen, Y.-W., Suen, M.-W., Satogami, K., Takahashi, S., Wu, C.-K., … Li, C.-T. (2022). Assessment of noninvasive brain stimulation interventions for negative symptoms of schizophrenia: A systematic review and network meta-analysis. JAMA Psychiatry, 79(8), 770–779.

[49] Wang, X., He, K., Chen, T., Shi, B., Yang, J., Geng, W., Zhang, L., Zhu, C., Ji, G., Tian, Y., Bai, T., Dong, Y., Luo, Y., Wang, K., & Yu, F. (2021). Therapeutic efficacy of connectivity-directed transcranial magnetic stimulation on anticipatory anhedonia. Depression and Anxiety, 38(9), 972–984.

[50] Zaehle, T., Rach, S., & Herrmann, C. S. (2010). Transcranial alternating current stimulation enhances individual alpha activity in human EEG. PLoS One, 5(11), e13766.

[51] Zhang, B., Lin, P., Shi, H., Öngür, D., Auerbach, R. P., Wang, X., Yao, S., & Wang, X. (2016). Mapping anhedonia-specific dysfunction in a transdiagnostic approach: An ALE meta-analysis. Brain Imaging and Behavior, 10(3), 920–939.

[52] Zhu, C.-Y., Hu, X.-W., Ju, X., & Sun, J.-J. (2022). Effectiveness of transcranial direct current stimulation therapy combined with Vortioxetine for patients with anhedonia depression. Chinese Journal of General Practice, 20(9), 1477–1480.

RIGHTS & PERMISSIONS

2023 The Authors. PsyCh Journal published by Institute of Psychology, Chinese Academy of Sciences and John Wiley & Sons Australia, Ltd.